OMX30 1 641 -0,1%  OMXH25 4 049 -0,8%  OMXC20 1 013 -0,2%  Dow 21 410 0,0%  Nas 5 777 -0,1%  EUR 9,7505 -0,2%  USD 8,7375 -0,1%  Olja 45,4 1,3%  Guld 1 251 0,3% 

STRATEC Biomedical Aktie

60,25EUR -0,06EUR -0,10%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

STRATEC Biomedical Chart - 1 År - XETRA

Fundamentala nyckeltal för STRATEC Biomedical

2016 2017e 2018e 2019e 2020e
Utdelning 0,77 0,82 0,95 1,17 1,25
Direktavkastning (i %) 1,70 1,39 1,61 1,98 2,12
PE-tal 21,29 24,53 21,36 18,30 17,18
Resultat/aktie 2,13 2,40 2,76 3,22 3,43

Nyheter om STRATEC Biomedical AG

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om STRATEC Biomedical AG

Apr, 25 2017 STRATEC Biomedical Hold Deutsche Bank AG
Apr, 21 2017 STRATEC Biomedical Buy Warburg Research
Apr, 20 2017 STRATEC Biomedical Buy Warburg Research
Mar, 16 2017 STRATEC Biomedical Buy Oddo Seydler Bank AG
Mar, 15 2017 STRATEC Biomedical Hold HSBC
ytterligare analyser

STRATEC Biomedical Peer Group

Agilent Technologies 60,15
0,6%
Baxter International 60,49
0,7%
Becton, Dickinson & 194,07
0,2%
Carl Zeiss Meditec 47,18
0,4%
Drägerwerk vz 96,98
-1,3%
Fresenius Medical Care 88,32
1,2%
Gerresheimer 72,96
0,5%
Pulsion Medical Systems 25,00
-7,4%
STRATEC Biomedical 60,25
-0,1%
Smith & Nephew 13,81
-0,1%
bioMerieux SA 196,70
-0,4%
pagehit

Lägg till instrument

Vad tycker du?

Profil STRATEC Biomedical AGtill bolagsprofilen

STRATEC Biomedical AG engages in the design and manufacture of automated analyzer systems in the field of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Consumables, and All Other. The Instrumentation segment refers to the design and manufacture of fully automated analyzer systems for its clinical diagnostic and biotechnology customers. The Diatron segment relates to the business of systems, system components, consumables and tests in the low through-put hematology and clinical chemistry. The Consumables segment is the business of development and sale of scientific materials such as nucleic acid purification, as well as the business of designing and manufacturing so-called smart consumables in the field of diagnostics, life sciences, and medical technology. The All Other segment is the development in workflow software for networking several analyzer systems, and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Realtidskurs STRATEC Biomedical AG

Bid
60,26
EUR
Ask
60,31
EUR
Kurstid
15:23
Börsen STU

Aktiekurs STRATEC Biomedical AG i EURPUSH CHART

Kurs 60,25 EUR -0,06 -0,10 %
Kurstid 16:26:57
Datum 22.06.2017
Öppning 60,00
Gårdagen 60,31
Dagshögsta 60,78
Dagslägsta 59,93
52 v. högsta 64,85
52 v. lägsta 41,30
52 v. perf.
Volym (Antal) 5 429
Börsvärde (SEK) 6,96 Mrd
Börsen
Kurs för 60,25 EUR från börsen XETRA motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 587,47 SEK.

Till aktien STRATEC Biomedical

Ticker
ISIN DE000STRA555
Index Prime All Share, CDAX, Technology All Share, BX Swiss - EMEA

STRATEC Biomedical Nyckeltal

Börsvärde i SEK 6,96 Mrd
Free float % 39,77
Antal aktier mio. 11,86
Cashflow/aktie i lokal valuta 1,37
Bokvärde/aktie i lokal valuta 12,12
60 dagar vola 35,08
PBV 3,74

STRATEC Biomedical Historiska kurser

2017-06-21 60,31 4 360
2017-06-20 60,49 5 045
2017-06-19 60,30 3 389
2017-06-16 59,16 8 107
2017-06-15 58,72 8 729

Aktier i samma industri med bättre 1 års perf.

m-u-t AG Meßgeräte für Medizin- und Umwelttechnik 139,2 %
CyBio AG 54,6 %
Sartorius AG Vz. 45,4 %
CeoTronics AG 32,0 %
Sartorius AG St. 31,8 %

Riktkurser för STRATEC Biomedical

Sell
Hold
Buy
50
55
60
65
70